Rockville, MD - Oct 16
... late-stage development – ONE, raxibacumab, already commercialized with sales to the U.S, Government and TWO moving toward ... products in collaboration with world leaders in the pharmaceutical industry. Further, in July 2009, we secured a new purchase order for 45,000 doses of raxibacumab, a drug to combat inhalational anthrax, to be ...